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A b s tra c t:  I n t r o d u c t i o n :  In d u c tio n  o f lab o r is an  in te rv en tio n  in  th e  obste trics, w hich  aim  is to 
achieve cervical r ip en in g  an d  stim ulate  co n trac tio n s o f  u te ru s before b eg in n in g  o f labor. The p u rpose  
o f o u r study  w as to evaluate efficacy o f com binations o f vag ina l m isoprosto l, in trace rv ica l d inoprostone  
an d  Foley cath e te r at te rm  w ith  regard  to m ode o f  delivery an d  ra te  o f  em ergency C -sections due to b irth  
asphyxia.
M a t e r i a l  a n d  M e t h o d s :  403 singleton  p reg n an t w om en, w ho u n d erw en t pharm aco log ica l labor 
in duction  at term , w ere reviewed. Patients were d iv ided  in to  2 m ain  cohorts due to  beg in n in g  o f induction  
algorithm : vaginal m isoprosto l (66) o r in tracerv ica l d inoprostone  (337) consisting  o f 3 subgroups — PGE2 
alone (184), PG E2+Foley cath e te r (125), PGE2+Foley catheter+PG E 1 (28).
R e s u l t s :  C om p ariso n  o f m ate rn a l age, p resence  o f cerv ica l d ila tio n  a n d  p a r ity  revealed  no  m ajor 
differences be tw een  coh o rts . Effectiveness o f  lab o r in d u c tio n  w ith  m iso p ro sto l, d in o p ro sto n e  and  
d in oprostone  follow ed by Foley cath e te r were respectively 90.9%, 51.3%, an d  82.8%. A dd ition  o f PGE1 
was effective in  83% o f p a tien ts w ith  negative response to PGE2 follow ed by Foley catheter. There was no 
sta tistica lly  significant difference in  ra te  o f  C -sections betw een d in o p ro sto n e  an d  m isoprosto l cohorts, 
C -section  due to  b ir th  asphyxia w ere insign ifican tly  m ore frequen t in  PGE1 th a n  in  PGE2 cohort. Efficacy 
in  th e  subgroup ad m in iste red  on ly  d in o p ro sto n e  was significantly  h ig h er in  40th th a n  in  41th (p = 0.016). 
C o n c l u s i o n s :  In tracerv ical d inoprostone  seems to  be safer, bu t less effective in  lab o r ind u ctio n  th an  
vag inal m isoprosto l. Follow ing PGE2 by o th er m eth o d s increased  efficacy o f ind u ctio n  in  th is  cohort.
Key w ords: in d u ctio n  o f labor, m isoprosto l, d inoprostone, Foley catheter, p rostag land ins.




Induction of labor is one of the most commonly performed interventions in the 
obstetrics. ^ e  aim of the procedure is to achieve cervical ripening and stimulate 
contractions of uterus before beginning of labor and it is performed due to fetal or 
obstetric indications (e.g. postterm  pregnancy, prelabor rupture of membranes at 
term) [1, 2]. Labor induction rate has risen in the recent decades leading to 1 in 4 
newborns in the UK in 2013-2014 being born with the help of this intervention [3]. 
Similar numbers and trends have been observed in other developed countries all over 
the world [4-6]. ^ e r e  are various methods of labor induction, which can be divided 
into non-pharmacological (i.e. amniotomy, mechanical m ethods including extra- 
amniotic Foley catheter or the Cook Cervical Ripening Baloon) and pharmacological 
(e.g. prostaglandins). Prostaglandins have been used for inducing labor since 1960s 
and are probably the most common methods of induction. ^ e y  can be administered 
orally, intravenously, extra-amniotically, vaginally or intracervically [7]. Local 
routes of administration reduce a risk of side effects, nonetheless all the methods of 
induction entail an increased risk of labor complications such as non-reassuring fetal 
status, emergency caesarean section or hyperstimulation [8-10]. Although there are 
several papers analyzing different methods of labor induction, there is still no strong 
evidence as for which method is the most effective and, at the same time, safe for both 
a woman and a child. Furthermore, only few studies compare vaginally administered 
prostaglandin E1 (misoprostol) and intracervically administered prostaglandin E2 
(dinoprostone) combined with mechanical methods of induction [11]. ^ e  aim of our 
study was to evaluate combinations of methods of inducing labour including vaginally 
administered misoprostol, intracervically administered dinoprostone in combination 
of Foley catheter and to determine, which of the methods has the highest effectiveness 
with regard to number of failures of induction, mode of delivery as well as rate of 
emergency caesarean sections due to birth asphyxia. Other investigated parameters 
were need of oxytocin. ^ e  analysis was performed for whole study population and 
for patients at full-term and post-term separately.
Material and Methods
180 women at full term  pregnancy (gestational age between 40 and 41 weeks — stayed 
in the text 40/52) and 233 women at post term (gestational age of 41 weeks and over 
— stayed in the text 41/52), who underwent pharmacological labor induction with 
intact membranes, were reviewed. Informed consent was obtained from all individuals 
on admission included in these study. In our study population (403 patients) first step 
of induction was pharmacological induction. Patients were divided into 2 groups.
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Group I (66 women) was inducted with 200 mcg vaginally administered misoprostol. 
Group II (337 patients) received 0.5 mg intracervically administered dinoprostone 
(Step 1). The women in study group I and II were compared in terms of age, BMI, 
parity, previous cervical procedures and presence or absence of cervical dilation, 
drugs abuse and gestational age at the time of prostaglandin application. The choice 
of the method of induction used for each woman was based on individual practitioner 
preferences. The women from group II whose initial labor induction with PGE2 was 
unsuccessful were consequently subjected to mechanical induction with the use of 
Foley catheter (FC) (Step 2). In case, when the induction with the catheter remained 
ineffective, the patients received PGE1 (Step 3). Algorithm is presented in Figure 1. 
Criteria of effectiveness for the individual groups included progress of cervical 
dilation or onset of labor within time specified in the corresponding Summaries of 
Product Characteristics and are presented in Table 1.
Table 1. C riteria  o f effectiveness o f p a rticu la r steps.
M ethod  
o f in d u ctio n







o f patien ts 
w ho received 
th e  step
PGE1
as beg in n in g  
o f in duction
Step 1
P rogress o f cervical d ila tion  
or
B eginn ing  o f labor 
up to  24 h
Lack o f progress 
o f cervical d ila tion  
and
B eginn ing  o f  labor 
after 24 h
I
p g e 2
as beg in n in g  
o f in duction
Step 1
P rogress o f cervical d ila tion  
or
B eginn ing  o f lab o r up  to 6  h
Lack o f progress 
o f cervical d ila tion  
and
B eginn ing  o f  labor 
after 6  h
W hole  group  II 




Foley ca theter 
after PGE2
Step 2
P rogress o f cervical d ila tion  
or
B eginn ing  o f labor 
up to  24 h
Lack o f progress 
o f cervical d ila tion  
and





PGE2 and  
Foley ca theter
Step 3
P rogress o f cervical d ila tion  
or
B eginn ing  o f labor 
up to  24 h
Lack o f progress 
o f cervical d ila tion  
and





Ineffective - STEP 3 Ineffective - no further Effective- PGE1 intervension
In total 28 In total 28 In total 98
41/52 20 41/52 14 41/52 61
40/52 8 40/52 14 J ^ 40/52 38
II A
Ineffective













11 A -  only step 1
II B -  steps 1 & 2
IIC -  steps 1 & 2 & 3
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The effectiveness of combinations of methods inside group II were also analyzed:
• Com bination of Step 1 and 1&2 (as achievement of expected effect after 
administration of PGE2 alone or PGE2 followed by Foley catheter — according to 
Table 1). Patients, who didn’t receive Foley catheter as Step 2 in spite of lack of 
effect after PGE 2 administration (part of group IIA — see Fig. 1) were excluded 
from this part of analysis (as the patients who did not complete the study).
• Combination of Step 1 and 1&2 and 1&2&3 (as achievement of expected effect 
after administration of PGE2 alone or PGE2 followed by Foley catheter or PGE2 
followed by Foley catheter and PGE1 — according to Table 1). Patients, who didn’t 
receive Foley catheter as Step 2 in spite of lack of effect after PGE2 administration 
(part of group IIA — see Fig. 1) and patients, who didn’t receive PGE1 as Step 3 
in spite of lack of effect after PGE2 and Foley catheter administration (part of 
group IIB — see Fig. 1) were excluded from this part of analysis (as the patients 
who did not complete the study).
Statistical analysis
Data were analyzed using STATISTICA 13.1 statistical analysis software. A value 
of p <0.05 was considered statistically significant. The normality was tested via 
Shapiro-W ilk test. Due to not fulfilled parametric test perquisites, relationships 
between qualitative and quantitative variables were assessed with the Chi-squared test 
and M ann-W hitney U test, respectively.
Results
Group I vs group II
General characteristics of the patients are presented in Table 2. Comparison of all 
the women who received initial labor induction with misoprostol (group I) to those 
administered dinoprostone (group II) revealed difference in median age of the 
patients (p = 0.04; PGE1 cohort was younger than PGE2 cohort, the median difference 
was 1 year). The groups did not differ with regards to parity, BMI, gestational age, 
previous cervical procedures, presence of cervical dilation, birth weight and drug 
abuse. In the whole study, there were significant differences in effectiveness; 90.9% 
vs 51.3% p  = 0.0000 for misoprostol and dinoprostone respectively. 70% of patients 
who responded to misoprostol delivered vaginally and 30% had a caesarean section. 
Birth asphyxia was indication in 21.7% patients, who underwent cesarean section; it 
constituted 72.2% as an indication of CS. In the group of the patients, who received 
dinoprostone, in case of effective induction — 72.8% women delivered vaginally 
and 27.2% had a caesarean section. In this group, birth asphyxia was indication for



































I 66 29 22.9 3.9 3 0 72.7 9.2 75.4 287 3590
II 337 30 22.5 4.5 1.8 0.6 73.9 5.8 63 287 3570
p -value — 0.04 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
I 41/52 33 30 22.7 4.8 0 0 72.3 18.8 75.4 287 3565
II 41/52 190 30 22,2 0 2.1 1.1 62.9 7 63 288 3610
p -value — >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 0.03 >0.05 >0.05 >0.05
I 40/52 33 30 23.1 9.1 6.1 0 71.4 0 78.1 284 3660
II 40/52 147 30 23.5 4.5 1.4 0.6 72.3 4.1 63.2 284 3500
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cesarean section in 12.7% of patients, it was an indication for 46.8% of CS (group IIA). 
Out of the patients who did not respond to dinoprostone (Step 1), 153 women 
were subjected to mechanical induction with the use of Foley catheter (Step 2). 
10 women from group IIA for whom induction was ineffective did not obtain any 
additional labor induction (5 started to deliver after more than 6h and 5 underwent 
caesarean section because of another contradictions, not connected with previously 
induction). They were excluded in further analysis (see Fig. 1). The induction with 
Foley catheter (Step 2) was successful in 63.4% of patients: 64.9% delivered vaginally 
and 35.1% had caesarean section — 20.6% due to birth asphyxia, which determined 
an indication for 58.8% of CS (group IIB). Out of the patients who did not meet the 
efficiency criteria for induction with Foley catheter, 9 women started to deliver after 
more than 24 hours after procedure and 19 underwent C-section because of other 
contradictions (not related to induction). These women weren’t included in further 
analysis (see Fig. 1). Out of the patients who did not respond to dinoprostone and 
mechanical induction (Step 2), 28 women were subjected to induction with the use 
of misoprostol (group IIC) (Step 3). This way of induction was successful in 82.2% of 
patients: 65.2% delivered vaginally and 34.8% had caesarean section (17.4% because 
of birth asphyxia — 50% of CS). Effectiveness of the induction in dinoprostone group 
is strongly related to gestational age at delivery — PGE2 is statistically more efficient 
when used for induction in 40/52 than in 41/52 (p = 0.016). Regarding PGE1, no 
correlation between efficacy of this prostaglandin and gestational age at delivery has 
been observed. No statistically significant differences in amount of caesarian sections, 
birth asphyxia frequency and proportion of birth asphyxia as indication for CS due to 
gestational age were observed in any group (Tables 3 and 4).
Group I vs group IIA
Differences in obstetric outcomes after administration only PGE1 and only PGE2 
are expressed by comparison of group I (administered only PGE1) and group IIA 
(administered only PGE2). There were not revealed any statistical differences in 
general characteristics. In the group I percentage of caesarian sections after effective 
induction reached 30% whereas in group IIA it was 27.2%. There was no statistically 
significant difference observed in delivery mode. Statistical analysis revealed no 
significant differences on need for oxytocin in groups I and IIA. Considering 
frequency of birth asphyxia, statistically significant difference was observed only in 
40/52 cohort (p = 0.049) and was absent in cohort 41/52 as in the whole study. 72% 
of CS in group I were performed because of birth asphyxia (and in cohort 40/52 it 
was indication for 87.5% of CS). However, comparison of indications for CS did not 
meet statistical criteria irrespective of gestational age.
Table 3. Effectiveness o f p a rticu la r steps — in to ta l and in subgroups by gestational age. 00ON
I II
Effectiveness 
o f Step 1
p -va lu e





Step 2 Step 3 I vs II — 41/52 0.000
(Foley catheter after (PGE1 after PG E , 
and Foley catheter)
I vs II — 40/52 0,000
41/52 vs 40/52 
group I(PGE)
>0.05
I II = IIA+IIB+IIC IIB+IIC IIC
41/52 vs 40/52 
group II(P G E )
0.016
Total 40/52 41/52 Total 40/52 41/52 Total 40/52 41/52 Total 40/52 41/52
Effectiveness 
o f the  Step [%]






Table 4. Results in indiv idual groups — in to ta l and in subgroups by gestational age.
I
(received Step 1 
-  PGE)
IIA
(received only  
Step 1 — PG E7, 
d id n ’t received 
Step 2 or Step 3)
p -va lue  
I vs IIA
IIB
(received Step 1 
— PG E7 and  
Step 2  — Foley 
cathether, d id n ’t 
received Step 3)
IIC
(received Step 1 
— PG E7 and  
Step 2 
— Foley catheter 
and Step 3 — P G E f
p -va lue  
I vs IIC
Total 40/52 41/52 Total 40/52 41/52 Total 40/52 41/52 Total 40/52 41/52 Total 40/52 41/52 Total 40/52 41/52
V aginal delivery if  
effective [%]
70 74.2 65.5 72.8 71.6 74.1 >0.05 >0.05 >0,05 64 .9 61.1 67.2 65.2 42.8 75 >0.05 >0.05 >0.05
CS i f  effective [%] 30 25.8 34.5 27.2 28.4 25.9 >0.05 >0.05 >0,05 35.1 38.9 32.8 34 .8 57.2 25 >0.05 >0.05 >0.05
B irth  asphyxia if  
effective [%]
21.7 22.6 13.8 12.7 14.8 10.6 >0.05 0.049 >0,05 20.6 25 18 17.4 28.6 12.5 >0.05 — —
Lack o f p rogress 
o f lab o r if  
effective [%]
8.3 3.2 20.7 14.5 13.6 15.3 >0.05 >0.05 >0,05 14.5 13.9 14.8 17.4 28.6 12.5 >0.05 — —
O xytocin  
a d m in is tra tio n  if  
effective [%]
22.2 29.6 14.8 28 .8 29.9 27.7 >0.05 >0.05 >0,05 75.8 68.6 80 45 42.9 46.2 0.01 >0.05 0.01
B irth  asphyxia as 
CS in d ica tio n  if  
effective [%]
72.2 87.5 40 46 .8 52 40.9 >0.05 0.049 >0,05 58 .8 64.3 55 50 50 50 >0.05 — —
Lack o f p rogress 
o f lab o r as CS 
in d ica tio n  if  
effective [%]
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Induction and birth weight
As for a birth weight, it is significantly correlated with a delivery mode. Among the 
women who were administered only dinoprostone (group IIA) differences in median 
body weight at birth met statistical significance criteria in the whole group of the 
patients (3700 g for CS versus 3470 g for a vaginal birth, p = 0.004536) as well as in 
the women in 41/52 (3720 g for CS versus 3500 g for a vaginal delivery, p = 0.019). 
No such association was found in the patients in 40/52 or in group I (the patients 
who initially received PGE1). In the group II (all the patients who initially received 
PGE2), the difference in median birth weights was 3635 g for caesarean section versus 
3505 g for vaginal delivery (p = 0.034).
Combination of Steps
Combination of Steps 1 and 1&2 (after excluding patients, who did not complete the 
study — see Methods) was successful in 82.8% of patients: 70% delivered vaginally 
and 30% had caesarean section (15,6% due to birth asphyxia — indication for 51.8% 
of CS). Combination of Steps 1 and 1&2 and 1&2&3 (after excluding patients, who 
did not complete the study — see Methods): was successful in 98.3% of patients: 
69.6% delivered vaginally and 30.4% had caesarean section (15.7% because of 
birth asphyxia — indication for 51.7% of CS). Results of particular steps and steps 
combinations are summarized in Table 5. Compared to PGE2 administration as the 
only one intervention, the combinations of steps were significantly more effective 
— both in the assessment of the whole population and for subgroups by gestational 
age (p ~0.00). There was no statistically significant difference in amount of caesarian 
sections, birth asphyxia frequency and proportion of birth asphyxia as indication for 
CS, but values of these parameters were higher in the group of patients who received 
combined intervention than in the group in which only PGE2 was used. Oxytocin 
was significantly more often administered in group with combined induction when 
assessing the whole population (p = 0.0016) as well as group 41/52 (p = 0.0017), but 
not 40/52.
The combination of Step 1 and 1&2 and 1&2&3 was significantly more effective 
than the combination of Steps 1 and 2 — regardless of gestational age (in total 
p = 0.0000, 41/52 p = 0.0021, 40/52 p = 0.0000). No significant difference was found 
in amount of caesarian sections, birth asphyxia frequency and proportion of birth 
asphyxia as indication for CS between those groups. The effectiveness of combination 
of Steps 1 and 1&2 was significantly higher in gestational age of 40 weeks than 
41 weeks (p = 0.012), similar to the effectiveness of PGE2 alone, while for combination 
of Steps 1 and 2 and 3 there were no significant differences in effectiveness depending 
on the gestational age. There was no difference in amount of caesarian sections, birth
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asphyxia frequency and proportion of birth asphyxia as indication for CS depending 
on gestational age observed in any combination. Obstetric outcomes of combinations 
of steps in group II were compared to outcomes obtained after administration of 
PGE1 in group I. The comparison of general characteristics of group in which patients 
received combination of 1 and 1&2 and group I revealed the statistically significant 
difference between mothers’ age for the whole study population (p = 0.0037; but the 
median difference was <1 year) and in the frequency of cervix intervention in the past 
(p = 0.0041) for the gestational age of 41 weeks. A similar difference in the history of 
cervix interventions in group of gestational age of 41 weeks was found in comparison 
of PGE1 group and group of patients who received combination of Steps 1 and 1&2 
and 1&2&3 (p = 0.0045). ^ e  interventions were more frequent in PGE1 group.
Com paring the results, oxytocin was significantly more often used in each 
combination than in PGE1 group for the whole study population and for gestational 
age of 41 weeks. No differences were found in amount of caesarian sections, birth 
asphyxia frequency and proportion of birth asphyxia as indication for CS.
^ e  effectiveness of the combination of Steps 1 and 1&2 did not differ significantly 
from the effectiveness of PGE1, while the effectiveness of combination of Steps 1 and 
1&2 and 1&2&3 significantly exceeded the effectiveness of the PGE1 — in the whole 
study population as well as in the subgroups by gestational age. ^ u s ,  the following 
relationship was observed: the effectiveness of PGE2 as an only intervention was 
significantly lower than the effectiveness of PGE1, the combination of 1 and 1&2 
was similarly effective as PGE1 and the combination of 1 and 1&2 and 1&2&3 was 
associated with higher efficiency than PGE1.
Group I vs IIC
Using PGE1 as Step 3 (group IIC) resulted in similar obstetric outcomes to those 
obtained by using this prostaglandin as Step 1 (group I). General characteristics 
of these two groups revealed significant difference in gestational age (p = 0.04). 
Obstetric outcomes — effectiveness, mode of delivery and CS indications did not vary 
significantly. Oxytocin was needed in group IIC more often. Group was not analyzed 
in subgroups due to poor plurality.
The whole population was analyzed with regards to factors reported to have 
strong effect on obstetric outcomes, such as initial cervical dilation, previous cervical 
procedures and parity. Neither an initial cervical dilation nor previous procedures on 
cervix had impact on efficacy of induction or mode of delivery, while primiparity was 
more often associated with caesarean section in the whole study population as well 
as in the group of women in 41/52. Nonetheless, no association between parity and 
effectiveness of induction was observed.
Table 5. Results o f th e  patients who received p a rticu la r steps and steps com binations of steps in group II — in to ta l and divided by gestational age. \oo
Step 1 (group II)
(PGE)
Step 1 & 1+ 2
(PGE2 or PGE2 
with Foley catheter)
Group I (PGEj)
— (detailed results 
in Table 4) vs Step 1 
and 1&2
p-value
Step 1 & 1+ 2 & 1+2+3
(PGE, or PGE, with 
Foley cathether or PGE, 
with Foley cathether 
with PGEJ
Group I (PGEj)
— (detailed results 
in Table 4) vs Step 1 
and 1&2 and 1&2&3
p-value
Total 40/52 41/52 Total 40/52 41/52 Total 40/52 41/52 Total 40/52 41/52 Total 40/52 41/52
Effectiveness of Step 
(according to Table 1) [%]
51.3 59.9 44.7 82.8 84.9 81.1 >0.05 >0.05 >0.05 98.3 99.2 97.6 0.0014 0.0041 0.0094
Vaginal delivery if effective 
[%]
72.8 71.6 74.1 70 68.6 71.2 >0.05 >0.05 >0.05 69.6 67.2 71.6 >0.05 >0.05 >0.05
CS if effective [%] 27.2 28.4 25.9 30 31.4 28.8 >0.05 >0.05 >0.05 30.4 32.8 28.4 >0.05 >0.05 >0.05
Birth asphyxia if effective [%] 12.7 14.8 10.6 15.6 17.7 13.7 >0.05 >0.05 >0.05 15.7 18.3 13.6 >0.05 >0.05 >0.05
Lack of progress of labor 
if effective [%]
14.5 13.6 15.3 14,4 13.7 15.1 >0.05 >0.05 >0.05 14.7 14.5 14.8 >0.05 >0.05 >0.05
Oxytocin administration 
if effective [%]
28.8 29.9 27.7 45.6 41.0 49.7 0.0014 >0.05 0.0008 45.6 41.1 49.4 0.0014 >0.05 0.0008
Birth asphyxia as CS 
indication if effective [%]
46.8 52 40.9 51.8 56.4 47.6 >0.05 >0.05 >0.05 51.7 55.8 47.8 >0.05 >0.05 >0.05
Lack of progress of labor 
as CS indication 
if effective [%]
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Table 5. Cont.
p -va lu e p-value p-value
Effectiveness o f  com bination Total 40/52 41/52
Step 1 vs any com bina tion  — irresp ec tiv e  o f  g e s ta tio n a l age 0 .000 — —
1 an d  1&2 vs 1 an d  1&2 an d  1&2&3 0.000 0.000 0.0021
p -va lu e
41/52 vs 40/52 — 1 an d  1&2 0.012 — —
41/52 vs 40/52 — 1 an d  1&2 an d  1&2&3 >0.05 — —
Discussion
The main objective of the study was to compare effectiveness of two pharmacological 
methods of labor induction (misoprostol and dinoprostone). The measurement can 
be obtained by comparing induction effectiveness between PGE1 and PGE2 group. 
PGE1 cohort, when compared to the patients who were given only PGE2 (with 
no further pharmacological or mechanical induction), had a significantly higher 
effectiveness of labor inductions, which remains consistent with other studies [12]. 
Comparison of labor inductions between the patients who were initially administered 
misoprostol and the patients who received dinoprostone followed by Foley catheter 
revealed no differences. Adding PGE1 as 3rd step of dinoprostone algorithm 
resulted in significantly higher effectiveness than the one achieved by application 
of misoprostol as first and only one intervention. In case of labor induction with 
only PGE2, the effectiveness of induction is significantly correlated with gestational 
age at delivery — dinoprostone seems to be more efficient in 40/52 than in 41/52. 
Whereas no difference in effectiveness of PGE1 depending on gestational age was 
revealed, we believe that in case of induction of labor in women in 41st gestational 
week obstetrician should rather consider the usage of PGE1 than PGE2 alone. Another 
important measure of labor induction effectiveness is oxytocin administration. In our 
study oxytocin augmentation was needed more frequently in the whole PGE2 cohort 
than in the patients, who received PGE1. Similar results can be found in other studies 
comparing vaginal dinoprostone with vaginally administered misoprostol [13-15]. 
Furthermore, Cochrane review from 2017 [16] states that the use of vaginally 
administered misoprostol is associated with a reduced need for oxytocin compared 
with the dinoprostone intracervical insert. The results may indicate greater potency of 
PGE1 in labor induction. In our study population there was no statistically significant 
difference in caesarean section rate between misoprostol and dinoprostone cohort, 
which remains in consonance with the review by Cochrane [16]. At the same time
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it appears that labor induction with PGE1 was slightly more often associated with 
delivery via caesarean section. In their trial Farnaz K. Aghideh et al. observed that 
the use of vaginal misoprostol significantly increased caesarean section rate among 
multiparous women, when compared to vaginally administered dinoprostone. Still, 
other studies have not made such an observation and remain consistent that caesarean 
section frequency does not depend on the drug used for pharmacological induction 
of labor. Analysis of indications for caesarean delivery in both groups revealed that 
birth asphyxia was more frequently listed among the patients induced with PGE1 than 
those induced with PGE2 — especially in gestational age of 40/52. The result remains 
consistent with other studies [12]. In addition, in our research this indication was 
responsible for nearly 73% of all caesarean sections in misoprostol cohort. Therefore, 
we strongly believe that maternal and fetal well-being in course of labor induction 
with misoprostol should be closely monitored with cardiotocography. To weakness 
of these study belongs retrospective character and lack of randomization. Patients 
were qualified to an induction by specialists in gynecology and obstetrics; clinical 
experience and management style can affect choice of induction agent and decision 
of cesarean section. A strength of the study is analyzing compound algorithm and 
effectiveness of each step, which can lead to valuable conclusions.
Conclusions
Intracervical dinoprostone is less effective in labor induction than vaginally 
administered misoprostol. However, when intracervical application of PGE2 is 
followed by other mechanical (Foley catheter) and pharmacological (PGE1 vaginal 
insert) methods, the efficacy of such combinations is higher than the effectiveness of 
misoprostol alone. High efficiency of a three-component labor induction demonstrates 
a strong effect of PGE1 on the cervix resistant to previously used PGE2 followed by 
Foley catheter. Noteworthy is the fact that among the patients who initially received 
PGE2, caesarean section rate and the risk of birth asphyxia is reported to slightly 
increase when combining dinoprostone with other methods of induction, but does 
not meet statistic criteria. Nevertheless, the use of dinoprostone in combination 
with other m ethods of induction seems to be associated with a similar rate of 
caesarean sections and insensibly decreased rate of birth asphyxia when compared to 
misoprostol administration.
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